Thomas Kim

Insider Reports History

Location
Chicago, IL
Signature
/s/ Blake Nielsen, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Kim:

Company Role Class Num Shares Value Price $ Report Date Ownership
Enfusion, Inc. Chief Executive Officer, Director Class A Common Stock 865,872 $7,489,793 $8.65 15 Jun 2022 Direct
Enfusion, Inc. Chief Executive Officer, Director Stock Option (Right to Buy) 32,000 15 Jun 2022 Direct

Insider Reports Filed by Thomas Kim

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ENFN Enfusion, Inc. 15 Jun 2022 2 $0 4 Chief Executive Officer, Director 17 Jun 2022, 21:46
ENFN Enfusion, Inc. 21 Oct 2021 0 $0 3 Chief Executive Officer, Director 21 Oct 2021, 20:44